IBDEI14B ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18136,0)
 ;;=E10.610^^61^804^9
 ;;^UTILITY(U,$J,358.3,18136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18136,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,18136,1,4,0)
 ;;=4^E10.610
 ;;^UTILITY(U,$J,358.3,18136,2)
 ;;=^5002613
 ;;^UTILITY(U,$J,358.3,18137,0)
 ;;=E10.618^^61^804^23
 ;;^UTILITY(U,$J,358.3,18137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18137,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,18137,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,18137,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,18138,0)
 ;;=E10.630^^61^804^30
 ;;^UTILITY(U,$J,358.3,18138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18138,1,3,0)
 ;;=3^DM Type 1 w/ Peridontal Disease
 ;;^UTILITY(U,$J,358.3,18138,1,4,0)
 ;;=4^E10.630
 ;;^UTILITY(U,$J,358.3,18138,2)
 ;;=^5002619
 ;;^UTILITY(U,$J,358.3,18139,0)
 ;;=E10.638^^61^804^27
 ;;^UTILITY(U,$J,358.3,18139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18139,1,3,0)
 ;;=3^DM Type 1 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,18139,1,4,0)
 ;;=4^E10.638
 ;;^UTILITY(U,$J,358.3,18139,2)
 ;;=^5002620
 ;;^UTILITY(U,$J,358.3,18140,0)
 ;;=E10.641^^61^804^15
 ;;^UTILITY(U,$J,358.3,18140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18140,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,18140,1,4,0)
 ;;=4^E10.641
 ;;^UTILITY(U,$J,358.3,18140,2)
 ;;=^5002621
 ;;^UTILITY(U,$J,358.3,18141,0)
 ;;=E10.649^^61^804^16
 ;;^UTILITY(U,$J,358.3,18141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18141,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,18141,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,18141,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,18142,0)
 ;;=E10.65^^61^804^14
 ;;^UTILITY(U,$J,358.3,18142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18142,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,18142,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,18142,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,18143,0)
 ;;=E10.69^^61^804^29
 ;;^UTILITY(U,$J,358.3,18143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18143,1,3,0)
 ;;=3^DM Type 1 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,18143,1,4,0)
 ;;=4^E10.69
 ;;^UTILITY(U,$J,358.3,18143,2)
 ;;=^5002624
 ;;^UTILITY(U,$J,358.3,18144,0)
 ;;=E10.8^^61^804^33
 ;;^UTILITY(U,$J,358.3,18144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18144,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,18144,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,18144,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,18145,0)
 ;;=E10.9^^61^804^34
 ;;^UTILITY(U,$J,358.3,18145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18145,1,3,0)
 ;;=3^DM Type 1 w/o Compl
 ;;^UTILITY(U,$J,358.3,18145,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,18145,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,18146,0)
 ;;=E10.620^^61^804^5
 ;;^UTILITY(U,$J,358.3,18146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18146,1,3,0)
 ;;=3^DM Type 1 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,18146,1,4,0)
 ;;=4^E10.620
 ;;^UTILITY(U,$J,358.3,18146,2)
 ;;=^5002615
 ;;^UTILITY(U,$J,358.3,18147,0)
 ;;=E10.36^^61^804^4
 ;;^UTILITY(U,$J,358.3,18147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18147,1,3,0)
 ;;=3^DM Type 1 w/ Diab Cataract
 ;;^UTILITY(U,$J,358.3,18147,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,18147,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,18148,0)
 ;;=E10.621^^61^804^6
 ;;^UTILITY(U,$J,358.3,18148,1,0)
 ;;=^358.31IA^4^2
